New $20 Billion Roadmap Aims to End ‘Diagnostic Odyssey’ for Women’s Health

Women in the United States live longer than men but often endure more years spent ill, a disparity that advocates say stems from decades of underfunding and insufficient research into female-specific health issues. In response, the Society for Women’s Health Research (SWHR) has unveiled a pioneering 10-year, $20 billion federal roadmap designed to transform how the nation approaches women’s healthcare.

Katie Schubert, president and CEO of SWHR, emphasized that the current investment gap is stark. Citing data from Melinda French Gates’ organization Pivotal, she noted that globally, only five cents of every medical research dollar is allocated to women’s health. Although the National Institutes of Health (NIH) budget dedicated to women’s health has risen since the organization’s founding in 1989, it now accounts for less than 10%, down from 13%.

The proposed strategy focuses on five key areas: research and innovation, inter-agency coordination, expanded clinical education and training, improved data collection, and enhanced health literacy. Schubert argued that funding alone is insufficient; the medical workforce must also be better equipped. She pointed out that until 1993, NIH scientists were not required to include women in clinical trials, a lag that contributes to what she termed a “diagnostic odyssey” for patients dealing with mysterious illnesses or conditions like cardiovascular disease and menopause.

“Menopause impacts 100% of the 51% of the population, yet we see millions directed toward other areas of research,” Schubert said, highlighting the imbalance relative to studies on men’s sexual health. She stressed that improving women’s health is an economic and social imperative, noting that women typically manage household healthcare decisions and drive significant spending into the system. Furthermore, closing the gender gap is seen as a pathway to addressing racial inequities, as historical exclusion from research has left a knowledge deficit regarding how diseases present in women of color.

More than 60 major health organizations, including the American Heart Association and the American College of Obstetricians and Gynecologists, have endorsed the roadmap. The group is now lobbying Congress to turn the funding proposal into policy. Schubert acknowledged the magnitude of the price tag but insisted it is necessary to rectify systemic issues rooted in centuries of sexism and racism.

Looking ahead, Schubert expressed optimism about the role of artificial intelligence in gathering more inclusive data, provided it is implemented correctly. For patients, she advised armoring oneself with knowledge and carefully vetting information sources, warning against relying solely on social media. As the push moves forward, the goal is to ensure policymakers cannot ignore the collective call for equitable medical research.